NurrOn Pharmaceuticals
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Phone Number
(781) 608-8144Website
www.nurronpharma.comRevenue
$9.4 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About NurrOn Pharmaceuticals
NurrOn Pharmaceuticals is a clinical-stage biopharmaceutical company based in Boston, USA, focused on developing innovative, disease-modifying therapies for Parkinson's disease and other Nurr1-related disorders. The company aims to enhance the quality of life for Parkinson's patients by creating targeted therapeutics that maximize efficacy while minimizing side effects. NurrOn's approach involves targeting Nurr1, a key regulator in dopaminergic neuron development, to slow or prevent disease progression. Their research includes both monotherapy and combination treatment strategies to improve clinical outcomes for patients.Explore more
Popular SearchesNurron Pharmaceuticals IncNurrOn PharmaceuticalsSIC Code 28,283NAICS Code 32,325Show more
NurrOn Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NurrOn Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when NurrOn Pharmaceuticals launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at NurrOn Pharmaceuticals
Earning: See what the market has to say on NurrOn Pharmaceuticals recently announced quarterly report
Click to see if NurrOn Pharmaceuticals had a recent Job posting/layoffs
Check out if NurrOn Pharmaceuticals is spiking on competitors!
Funding: Get notified immidiatlly once NurrOn Pharmaceuticals has new funding data
Check if NurrOn Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
NurrOn Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at NurrOn Pharmaceuticals
Find more new buyers
Compare Similar Companies to NurrOn Pharmaceuticals
Compare insights from companies similar to NurrOn Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
1-10
Private
-
2011
Mark KlevenSenior Vice President, Scientific Operations, Chief Operating Officer
Company Profile Activity
Activity Insights
NurrOn Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NurrOn Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NurrOn Pharmaceuticals.
NurrOn Pharmaceuticals Tech Stack
A closer look at the technologies used by NurrOn Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NurrOn Pharmaceuticals
Sign Up For FreeTo access detailed company insights
NurrOn Pharmaceuticals is a clinical-stage biopharmaceutical company based in Boston, USA, focused on developing innovative, disease-modifying therapies for Parkinson's disease and other Nurr1-related disorders. The company aims to enhance the quality of life for Parkinson's patients by creating targeted therapeutics that maximize efficacy while mi... Read More
